Plain-English translation of NCT05713136 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Hepatitis C research guide →This study is looking at whether offering a quick, simple finger-prick blood test for hepatitis C can help more people get diagnosed and start treatment. Researchers want to see how many people who test positive actually begin treatment within 12 weeks. The study will recruit 40,000 adults from clinics and services in Australia that work with people at higher risk for hepatitis C.
Hepatitis C is a serious liver infection that can be cured, but many people don't know they have it because testing hasn't been easy to access. This study wants to find out if offering a quick, simple finger-prick test at the point of care — rather than requiring a visit to a lab — will help more people get tested, diagnosed, and connected to treatment.
You likely qualify if…
You likely don't qualify if…
You will come in for one visit where staff will explain the study and get your permission to participate. At that visit, you'll receive a quick finger-prick blood test to check for hepatitis C. If you test positive or have a history of hepatitis C, you'll get a confirmatory test on the same day. If you're diagnosed with hepatitis C, the study staff will refer you to standard care for treatment — the study itself does not provide treatment. Twelve weeks after your test result, researchers will check your medical records to see if you started treatment.
AI-generated summary from trial data · Jun 3, 2026 · Not medical advice
Australia